Document is current
Any future updates will be listed below
-
Authors
Dunlop, Adrian https://orcid.org/0000-0003-2394-5966
Lokuge, Buddhima
Masters, Debbie
Sequeira, Marcia
Saul, Peter
Dunlop, Grace
Ryan, John
Hall, Michelle
Ezard, Nadine
Haber, Paul
Lintzeris, Nicholas
Maher, Lisa
- License Information
-
More Information
Article History
Received: 29 March 2020
Accepted: 24 April 2020
First Online: 6 May 2020
Ethics approval and consent to participate
: There are no data relating to individuals in the text; therefore, institutional ethics committee clearance has not been sought regarding this manuscript.
: Not applicable
: A.D. reports grants from Braeburn/Camurus AB, to conduct clinical studies with buprenorphine products and travel support to Hunter New England Local Health District, which employs A.D. A.D is an investigator on an Indivior-funded study of buprenorphine products. A.D has serviced on an advisory board for Mundipharma.P.H. reports grants from Braeburn/Camurus AB to conduct clinical studies with buprenorphine products to Sydney Local Health District, which employs P.H.N.L. has received funding from Braeburn, Camurus and Indivior to conduct clinical studies with buprenorphine products and has served on advisory boards for Indivior and Mundipharma.A.D., B.L., D.M., M.S., P.S. and M.H. are employed by Hunter New England Local Health District, a public health service funded by the NSW Ministry of Health.P.H. is employed by Sydney Local Health District, a public health service funded by the NSW Ministry of Health.N.L. is employed by Sydney South East Local Health District, a public health service funded by the NSW Ministry of Health.There are no other author interests to declare.
